Insulin resistance and fuel homeostasis: the role of AMP‐activated protein kinase
- 1 April 2009
- journal article
- review article
- Published by Wiley in Acta Physiologica
- Vol. 196 (1), 129-145
- https://doi.org/10.1111/j.1748-1716.2009.01968.x
Abstract
The worldwide prevalence of type 2 diabetes (T2D) and related disorders of the metabolic syndrome (MS) has reached epidemic proportions. Insulin resistance (IR) is a major perturbation that characterizes these disorders. Extra-adipose accumulation of lipid, particularly within the liver and skeletal muscle, is closely linked with the development of IR. The AMP-activated protein kinase (AMPK) pathway plays an important role in the regulation of both lipid and glucose metabolism. Through its effects to increase fatty acid oxidation and inhibit lipogenesis, AMPK activity in the liver and skeletal muscle could be expected to ameliorate lipid accumulation and associated IR in these tissues. In addition, AMPK promotes glucose uptake into skeletal muscle and suppresses glucose output from the liver via insulin-independent mechanisms. These characteristics make AMPK a highly attractive target for the development of strategies to curb the prevalence and costs of T2D. Recent insights into the regulation of AMPK and mechanisms by which it modulates fuel metabolism in liver and skeletal muscle are discussed here. In addition, we consider the arguments for and against the hypothesis that dysfunctional AMPK contributes to IR. Finally we review studies which assess AMPK as an appropriate target for the prevention and treatment of T2D and MS.Keywords
This publication has 106 references indexed in Scilit:
- Beyond AICA riboside: In search of new specific AMP-activated protein kinase activatorsIUBMB Life, 2008
- AMPK and PPARδ Agonists Are Exercise MimeticsCell, 2008
- Evidence for AMPK-dependent regulation of exocytosis of lipoproteins in a model liver cell lineExperimental Cell Research, 2008
- Selective versus Total Insulin Resistance: A Pathogenic ParadoxCell Metabolism, 2008
- Resveratrol improves health and survival of mice on a high-calorie dietNature, 2006
- The CREB coactivator TORC2 is a key regulator of fasting glucose metabolismNature, 2005
- Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespanNature, 2003
- Cloning of adiponectin receptors that mediate antidiabetic metabolic effectsNature, 2003
- Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinaseNature, 2002
- Transcriptional regulation by the phosphorylation-dependent factor CREBNature Reviews Molecular Cell Biology, 2001